Alzheimer’s is a continuing nerve related disease which gradually worsens over time. The nervous system, especially the neurons in the brain of an individual, degenerate over time in this disease and the most common symptom is memory loss. Galantamine, a cholinesterase inhibitor, is one of the most promising drugs used for the treatment of central nervous system (CNS) disorders including Alzheimer’s. Read more
The California Drug Addiction Helpline is committed to helping those who struggle with drug addiction find treatment. These resources will provide readers with articles and up to date reports on issues regarding drug addiction and treatment. Check back often for new and exciting material.
Fentanyl is a powerful synthetic opioid originally developed to treat excruciating pain arising from cancer. Considered to be nearly 50 times stronger than heroin, it provides instant relief from pain. However, it is also used recreationally and often mixed with other drugs like heroin, cocaine, or alcohol to achieve a more dominant high. According to the National Survey on Drug Use and Health (NSDUH) 2018 report, nearly 269,000 people aged 12 years and above have misused prescription fentanyl. Unfortunately, fentanyl has also been reported as the main cause in thousands of overdoses every year in the U.S. Read more
Buprenorphine is a crucial part of any addiction treatment in the United States. However, experts feel that it is not uniformly prescribed to patients visiting a doctor’s clinic for addiction treatment. To explore this belief further, researchers from the University of Michigan recently conducted a study to find out how often patients belonging to different races and backgrounds were prescribed Buprenorphine during their visit to the doctor’s clinic. Buprenorphine is currently the most favored drug for opioid addiction treatment in the U.S. Read more
The National Institutes of Health Clinical Center has begun a research on a drug developed to deal with the cravings linked with opioid use. The clinical trial would test the safety of the active compound in the drug, ANS-6637, in healthy individuals. It would also look at how the body processes the drug when administered with an additional drug metabolized by similar liver enzymes. The trial is being conducted with the help of NIH’s National Institute of Allergy and Infectious Diseases (NIAID), and funded by the NIH’s Helping to End Addiction Long-Term (HEAL) Initiative. This is an extensive program to fast-track the research endeavors to curtail the opioid epidemic, which has become a public health crisis. Read more
Preschoolers and children in elementary school are young, curious and impressionable. As a parent, one can use these years to lay the foundation of a drug-free life for their children. This can be achieved by interacting with them in a way that holds their interest and at the same time, inculcates in them the perils of using drugs and alcohol.
However, for most parents, talking to young children about such a sensitive topic could be challenging. Given below are some tips which can help one get started about drug talk with their children without feeling awkward or tense. Read more
About Our Helpline
Latest Blog Posts
- Prelim studies show cholinesterase inhibitors can help treat opioid addictionNovember 13, 2019 - 6:29 am
- Dreaded fentanyl reaches CaliforniaSeptember 24, 2019 - 6:17 am
- Addiction treatment more accessible to white patients, says studyJune 7, 2019 - 5:31 am
- Clinical trial begins for an experimental drug for opioid cravingsMay 27, 2019 - 11:49 am